Madrigal Pharmaceuticals (MDGL) Financials: Revenue & Earnings

MDGL price $427.93 -12.40 -2.82%

Ticker
MDGL
Price
$427.93
Change
-12.40 -2.82%
Market cap ?
$9.89B
P/E ?
-33.96
Forward P/E ?
75.33
Dividend yield ?
0.00%
Beta ?
-1.05
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
64
Value
48
Quality
44
Growth
100

Stocklytics score rationale: value 48, quality 44, growth 100.

Financials

2016201720182019202020212022202320242025
00000000180133000958403000

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for…

Fair value

MDGL fair value $309.78. Price $427.93. Price is 38% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 250.96M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.00%. Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 23.10M. Net debt 155.67M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare MDGL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-0.86—404.17M
2026-07-30-1.99-2.68364.30M352.13M
2026-05-06-3.25-3.61311.34M301.05M
2026-02-19-2.570.04321.10M312.51M
2025-11-04-5.08-2.04287.27M244.96M
2025-08-05-1.90-3.48212.80M243.47M
2025-05-01-3.32-3.62137.25M158.93M
2025-02-26-2.71-4.32103.32M97.81M
2024-10-31-4.92-6.9462.17M92.53M
2024-08-07-7.10-7.5514.64M3.90M
2024-05-07-7.38-6.06—3.90M
2024-02-28-5.68-5.32770.00K—
2023-11-06-5.34-4.78——
2023-08-08-4.69-4.47——
2023-05-09-4.23-4.98——
2023-02-23-4.98-4.41——
2022-11-03-4.75-4.05——
2022-08-04-4.14-3.76——
2022-05-09-3.36-3.75——
2022-02-24-3.78-3.92——
2021-11-04-3.79-3.89——
2021-08-05-3.72-3.55——
2021-05-06-3.32-3.78——
2021-02-25-3.82-3.82——
2020-11-05-3.75-3.35—4.83M
2020-08-06-3.18-2.42—4.34M
2020-05-07-2.34-1.94——
2020-02-26-1.80-1.56—4.62M
2019-11-06-1.39-1.36—5.19M
2019-08-07-1.28-1.08—6.67M
2019-05-08-0.98-0.93—5.69M
2019-02-27-0.75-0.75——
2018-11-06-0.56-0.54——
2018-08-07-0.45-0.56——
2018-05-08-0.45-0.75——
2018-03-13-0.67-0.68——
2017-11-09-0.68-0.84——
2017-08-10-0.69-0.60—1.41M
2017-05-11-0.50-1.39——
2017-04-03-0.67———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-11Sibold William JohnSell60$533.0931.99K
2026-09-11Sibold William JohnSell106$534.0656.61K
2026-09-11Sibold William JohnSell218$535.94116.84K
2026-09-11Sibold William JohnSell160$537.6286.02K
2026-09-11Sibold William JohnSell687$540.59371.38K
2026-09-11Sibold William JohnSell368$541.64199.32K
2026-09-11Sibold William JohnSell1.20K$542.60652.21K
2026-09-11Sibold William JohnSell1.54K$544.02837.25K
2026-09-11Sibold William JohnSell761$544.83414.62K
2026-09-11Sibold William JohnSell120$546.3865.57K
2026-09-09Sibold William JohnSell131$527.8869.15K
2026-09-09Sibold William JohnSell347$529.27183.66K
2026-09-09Sibold William JohnSell522$530.23276.78K
2026-09-09Sibold William JohnSell368$531.99195.77K
2026-09-09Sibold William JohnSell512$533.09272.94K
2026-09-09Sibold William JohnSell396$534.20211.54K
2026-09-09Sibold William JohnSell644$535.27344.72K
2026-09-09Sibold William JohnSell1.04K$536.11557.56K
2026-09-09Sibold William JohnSell640$537.17343.79K
2026-09-09Sibold William JohnSell520$538.30279.91K
2026-09-09Sibold William JohnSell215$539.03115.89K
2026-09-09Sibold William JohnSell505$540.19272.80K
2026-09-09Sibold William JohnSell362$541.65196.08K
2026-09-09Sibold William JohnSell160$542.5586.81K
2026-08-17Kelley Shannon TSell664$514.97341.94K
2026-08-15REED JOHN CBuy1.08K$507.56547.15K
2026-08-15REED JOHN CBuy647——
2026-08-11REED JOHN COther0——
2026-07-20Sibold William JohnSell140$542.7575.98K
2026-07-20Sibold William JohnSell110$543.7959.82K
2026-07-20Sibold William JohnSell545$544.71296.87K
2026-07-20Sibold William JohnSell275$545.71150.07K
2026-07-20Sibold William JohnSell269$547.08147.16K
2026-07-20Sibold William JohnSell680$547.70372.43K
2026-07-20Sibold William JohnSell47$548.8725.80K
2026-07-20Sibold William JohnSell153$550.0184.15K
2026-07-20Sibold William JohnSell1$550.72551
2026-07-20Sibold William JohnSell280$555.05155.41K
2026-07-17Sibold William JohnBuy50.00K——
2026-07-17Sibold William JohnSell50.00K——
2026-06-17Taub RebeccaBuy454——
2026-06-17Taub RebeccaBuy766$499.86382.89K
2026-06-17Levy Richard SBuy454——
2026-06-17Levy Richard SBuy766$499.86382.89K
2026-06-17FOUSE JACQUALYN ABuy454——
2026-06-17FOUSE JACQUALYN ABuy766$499.86382.89K
2026-06-17Daly James MBuy454——
2026-06-17Daly James MBuy766$499.86382.89K
2026-06-17Brennan Daniel J.Buy404——
2026-06-17Brennan Daniel J.Buy681$499.86340.40K
2026-06-17BAKER BROS. ADVISORS LPBuy908——
2026-06-17BAKER BROS. ADVISORS LPBuy908——
2026-06-17BAKER BROS. ADVISORS LPBuy1.53K$499.86765.79K
2026-06-01Soergel DavidSell1.04K$495.74516.56K
2026-05-22Levy Richard SSell40$506.6820.27K
2026-05-22Levy Richard SSell320$508.24162.64K
2026-05-22Levy Richard SSell151$510.3677.06K
2026-05-22Levy Richard SSell610$511.40311.95K
2026-05-22Levy Richard SSell439$512.50224.99K
2026-05-22Levy Richard SSell40$512.9720.52K
2026-05-22Levy Richard SSell343$514.67176.53K
2026-05-22Levy Richard SSell657$515.92338.96K
2026-05-22Levy Richard SSell723$516.87373.69K
2026-05-22Levy Richard SSell1.50K$517.59774.84K
2026-05-22Levy Richard SSell782$518.76405.67K
2026-05-22Levy Richard SSell80$519.9841.60K
2026-05-18Soergel DavidSell844$515.90435.42K
2026-03-06Dier MardiSell646$431.94279.03K
2026-03-06Dier MardiSell40$425.0817.00K
2026-03-06Dier MardiSell420$426.86179.28K
2026-03-06Dier MardiSell80$427.8534.23K
2026-03-06Dier MardiSell160$429.0068.64K
2026-03-06Dier MardiSell40$429.5817.18K
2026-03-06Dier MardiSell120$430.9051.71K
2026-03-06Dier MardiSell116$432.5650.18K
2026-03-06Dier MardiSell160$434.2069.47K
2026-03-06Dier MardiSell80$435.3134.83K
2026-03-06Dier MardiSell80$436.6934.94K
2026-03-06Dier MardiSell40$437.6517.51K
2026-03-06Sibold William JohnSell1.66K$431.94718.32K
2026-03-06Kelley Shannon TSell360$431.94155.50K
2026-03-06Huntsman CaroleSell419$431.94180.98K
2026-03-06Taub RebeccaSell491$431.94212.08K
2026-03-04Dier MardiBuy5.21K——
2026-03-04Dier MardiBuy6.52K$434.802.83M
2026-03-04Sibold William JohnBuy14.99K——
2026-03-04Sibold William JohnBuy18.74K$434.808.15M
2026-03-04Kelley Shannon TBuy4.02K——
2026-03-04Kelley Shannon TBuy5.02K$434.802.18M
2026-03-04Huntsman CaroleBuy3.99K——
2026-03-04Huntsman CaroleBuy4.99K$434.802.17M
2026-03-04Soergel DavidBuy4.37K——
2026-03-04Soergel DavidBuy5.47K$434.802.38M
2026-03-02Dier MardiSell1.18K$427.21505.39K
2026-02-23Levy Richard SBuy2.50K$7.3618.40K
2026-02-23Levy Richard SSell2.50K$7.3618.40K
2026-01-26Levy Richard SBuy4.00K$16.4665.84K
2026-01-26Levy Richard SSell4.00K$16.4665.84K
2026-01-26Huntsman CaroleSell340$492.42167.42K
2026-01-26Huntsman CaroleSell570$494.59281.92K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 439, holders +31 vs prior quarter. Ownership 81.57%.

HolderSharesChangeChange %Value
BAKER BROS. ADVISORS LP2.14M1.43K+0.07%1.15B
RTW INVESTMENTS, LP1.99M00.00%1.07B
JUPITER TOPCO LLC1.94M1.94MNew1.04B
AVORO CAPITAL ADVISORS LLC1.83M15.15K+0.83%984.41M
PAULSON & CO. INC.1.34M-52.17K-3.75%719.52M
BLACKROCK, INC.1.20M-359.19K-23.03%644.75M
VANGUARD CAPITAL MANAGEMENT LLC835.67K8.52K+1.03%448.71M
WELLINGTON MANAGEMENT GROUP LLP825.71K130.76K+18.81%443.37M
VANGUARD PORTFOLIO MANAGEMENT LLC781.73K-59.41K-7.06%419.75M
STATE STREET CORP527.06K-82.47K-13.53%283.00M
CITADEL ADVISORS LLC507.23K470.93K+1297.34%272.36M
UBS GROUP AG401.71K283.93K+241.07%215.70M
GEODE CAPITAL MANAGEMENT, LLC374.88K-80.99K-17.77%201.34M
FMR LLC356.20K-155.53K-30.39%191.26M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC324.12K-16.40K-4.82%174.04M
INVESCO LTD.301.44K-28.08K-8.52%161.86M
ARMISTICE CAPITAL, LLC288.00K23.42K+8.85%154.64M
LORD, ABBETT & CO. LLC281.50K38.77K+15.97%151.15M
GOLDMAN SACHS GROUP INC246.28K-31.09K-11.21%132.24M
POLAR CAPITAL HOLDINGS PLC244.27K-45.04K-15.57%131.16M
AMERIPRISE FINANCIAL INC231.21K133.02K+135.49%124.15M
NORGES BANK213.89K213.89KNew114.85M
ARTISAN PARTNERS LIMITED PARTNERSHIP210.21K26.66K+14.53%112.87M
SUSQUEHANNA INTERNATIONAL GROUP, LLP209.80K187.58K+844.36%112.65M
PICTET ASSET MANAGEMENT HOLDING SA192.90K5.66K+3.02%103.49M

Earnings and financials

Madrigal Pharmaceuticals, Inc. (MDGL) trades at $427.93, with a market cap of $9.89B and a trailing P/E of -33.96. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
00000000180133000958403000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Madrigal Pharmaceuticals (MDGL) Financials: Revenue & Earnings

MDGL$427.93-12.40 -2.82%

$9.89B

Market Cap

-33.96

P/E

75.33

Forward P/E

64

Score

Price History